APA (7th ed.) Citation

SS, R., D, B. V., S, S., D, V., MR, M., BA, V., . . . SM, C. (2025). 225Ac α-Pretargeted Radioimmunotherapy of Human Epidermal Growth Factor Receptor 2-Expressing Breast Cancer. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 66(11), 1714. https://doi.org/10.2967/jnumed.125.269601

Chicago Style (17th ed.) Citation

SS, Rinne, et al. "225Ac α-Pretargeted Radioimmunotherapy of Human Epidermal Growth Factor Receptor 2-Expressing Breast Cancer." Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine 66, no. 11 (2025): 1714. https://doi.org/10.2967/jnumed.125.269601.

MLA (9th ed.) Citation

SS, Rinne, et al. "225Ac α-Pretargeted Radioimmunotherapy of Human Epidermal Growth Factor Receptor 2-Expressing Breast Cancer." Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine, vol. 66, no. 11, 2025, p. 1714, https://doi.org/10.2967/jnumed.125.269601.